title: Heart rate variability, a target for the effects of angiotensin II in the brain of the trout Oncorhynchus mykiss.
abstract: This study was conducted on unanesthetized rainbow trout equipped with two ECG electrodes and with an intracerebroventricular (i.c.v.) micro-guide. The ECG signal was recorded during three experimental sessions of 30 min and the heart rate variability (HRV) spectral analysis was performed during stabilized periods of recording. The first recording session was conducted during the control period and the mean heart rate (HR) of the trout was 44+/-2 bpm. The total power spectral density (PSD) of the R-R interval signal of the ECG was 21233+/-4400 ms(2)/Hz. A major high frequency (HF) spectral band centered at 0.16 Hz and a minor low frequency (LF) spectral band centered at 0.04 Hz were the two main components of the PSD. An i.c.v. injection of 0.5 microl of vehicle during the second session had no significant statistical effect, either on the mean HR (43+/-2 bpm), the total PSD (24693+/-6394 ms(2)/Hz) or on the center frequency and power of the two main spectral bands. Conversely, an i.c.v. injection of ANGII (1.5, 6.25 and 50 pmol) during the third recording session induced a significant increase in the mean HR (+3%, +15%, +30%, respectively) but the effect of the peptide was more obvious on the total PSD which was profoundly decreased (-27%, -65%, -76%, respectively). The two main spectral bands of the PSD were totally blunted after the injection of 50 pmol of ANGII. In another group of control trout, intraperitoneal (i.p.) injection of atropine abolished the PSD of the R-R interval signal of the ECG demonstrating that the parasympathetic system is the main contributor of HRV in trout. Our results have thus demonstrated for the first time, at least in a non-mammalian species, that i.c.v. injection of native ANGII profoundly reduces HRV. We hypothesize that ANGII in the brain of the trout alters the pattern of the electrical activity along preganglionic cardiac vagal motoneurons.
authors.affiliation: LATIM (EA 2218), INSERM ERM 0102, Laboratoire de Neurophysiologie, UFR de Médecine, Université de Bretagne Occidentale, 22 avenue Camille Desmoulins, 29285 Brest Cedex, France. jean-claude.lemevel@univ-brest.fr
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Le Mével
authors.forename: Nagi
authors.initials: N
authors.lastname: Mimassi
authors.forename: Frédéric
authors.initials: F
authors.lastname: Lancien
authors.forename: Dominique
authors.initials: D
authors.lastname: Mabin
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Boucher
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Blanc
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000502:physiology*; D004562:Electrocardiography / Q000187:drug effects; D006321:Heart / Q000294:innervation; D006339:Heart Rate / Q000502:physiology*; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D018727:Muscarinic Antagonists / Q000494:pharmacology; D017686:Oncorhynchus mykiss / Q000502:physiology*; D014630:Vagus Nerve / Q000502:physiology
chemical_list: D018727:Muscarinic Antagonists; D000804:Angiotensin II; D001285:Atropine